Brief: Engene Holdings Inc - To Change Name To Engene Therapeutics Inc. Effective April 8, 2026
07/04/2026 13:04
April 7 (Reuters) - enGene Holdings Inc ENGN.O: ENGENE HOLDINGS INC - TO CHANGE NAME TO ENGENE THERAPEUTICS INC. EFFECTIVE APRIL 8, 2026 ENGENE HOLDINGS INC - PLANNED BLA SUBMISSION FOR DETALIMOGENE IN SECOND HALF OF 2026 Source text: ID:nBw4R7Vl1a Further company coverage: ENGN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on enGene Therapeutics
See all newsBrief: Engene Reports Second Quarter 2026 Financial Results And Provides Business Update
enGene Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Engene Holdings Inc - To Change Name To Engene Therapeutics Inc. Effective April 8, 2026
Brief: Engene Holdings Enters Sales Agreement With Leerink Partners To Sell Common Shares
Brief: enGene Reports First Quarter 2026 Financial Results and Provides Business Update